Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma.
about
Why cancer and inflammation?The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatinEffect of sulindac sulfide on metallohydrolases in the human colon cancer cell line HT-29.A comparative analysis of gene-expression data of multiple cancer types.Heparinoids activate a protease, secreted by mucosa and tumors, via tethering supplemented by allostery.Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.Clinical implications of Fas/Fas ligand expression in patients with esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy.KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora A activity.Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cellsPrognostic significance of matrix metalloproteinase 7 immunohistochemical expression in colorectal cancer: a meta-analysis.Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinomaExpression of c-Myc and Fas correlates with perineural invasion of pancreatic cancer.The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression.Genetic polymorphisms in the MMP-7 gene and breast cancer survivalA novel orthotopic mouse model of head and neck cancer and lymph node metastasisMatrilysin-1 mediates bronchiolization of alveoli, a potential premalignant change in lung cancer.Targeting cell death signaling in colorectal cancer: current strategies and future perspectives.FAS system deregulation in T-cell lymphoblastic lymphomaMatrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets.Stiff substrates increase YAP-signaling-mediated matrix metalloproteinase-7 expression.Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), an anticancer agent, exerts an anti-inflammatory effect in activated human mast cells.Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer.Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.Matrix metalloproteinase-2 and -7 expression in colorectal cancer.Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer.MMP-7 as a prognostic marker in colorectal cancer.Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma.Marine steroid derived from Acropora formosa enhances mitochondrial-mediated apoptosis in non-small cell lung cancer cells.23-hydroxybetulinic acid-induced HL-60 cell autophagic apoptosis and its molecular mechanism.
P2860
Q24680891-BDFCBDF4-2258-46AD-8B6C-358195CDDA86Q28474925-AAC4AAC9-AA17-418B-89A5-B5FB1108B3F3Q31032481-B47E5A7E-94D8-4D47-AAB6-E27673456E00Q33742162-4F780119-4BAE-4C71-ACCF-52F2098959FEQ33777230-BA2304D4-A73E-41CB-8E7B-9FD3A93D0D6CQ33952599-25995154-CA8A-4594-BB6E-839F1C9AA08AQ34607210-14541747-2098-49DA-96BB-0044D64ADFDFQ35005238-2DA087B7-E29A-49D6-AB56-6B0A98721317Q35616512-AECA6C25-2CDD-4F8E-A0EE-71C83385081AQ35618147-4D8E27EB-3514-4F0D-92A4-388A3EBE95F6Q35643502-9EBF3E0F-22FD-40C8-BA8F-7AF3CE553E54Q35840582-2B5C83A9-74EF-45D9-95FC-364DB282F6FAQ36003265-DB26B4B1-603A-43A4-B770-2BE4B3CC54E7Q36098052-234351BE-DB19-4E19-B10F-B863F759A0A9Q37003874-A87E9D4B-3E3B-4984-8218-974CAB1E2289Q37275756-0625E7CD-526E-46C5-B5FA-BD240A98AE4FQ37278448-995C99A8-2898-4338-B42C-38911795B822Q37602717-4F1872A4-DF13-463E-BFC0-9D575EEE3A2EQ37680225-83A8F7D5-02CD-4DE6-AB8B-4BE2E58B2FD3Q38107451-D3CBB362-6773-429F-BF72-22D455EFE7B1Q38636963-6D86EDCC-53C4-4122-8DCE-1E7800C6B02FQ38700300-131EE2C3-F941-44AD-B39A-29E0150B7725Q39444496-4F04056A-F457-49F0-8919-E672E1A63C3BQ40063874-89B13705-06EB-46D4-A7DC-589D8E25D4ABQ42292364-23B5CB59-DD59-44E6-85C4-B9B7C95BAF53Q42846414-89268FF5-27BA-4C8A-A7F2-5D6B39577BFCQ43578829-34A3CE00-51DC-42BF-BA1D-3D95267310B3Q43901283-19A50B72-95A7-4F20-91E6-AEBEAA6CC947Q45177603-3D04EB0D-30B3-448D-AFFB-B5903496ED3BQ45241710-02F248A7-36F6-47EF-A713-24880EEA09F6Q46599463-35C44C51-CE2A-49F9-B5E6-FA274D2EF629Q53212139-81E11A5F-6FBF-4CB4-A3F6-DC7CBCFE07AF
P2860
Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Matrix metalloproteinase-7 inc ...... nts with colorectal carcinoma.
@en
type
label
Matrix metalloproteinase-7 inc ...... nts with colorectal carcinoma.
@en
prefLabel
Matrix metalloproteinase-7 inc ...... nts with colorectal carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Matrix metalloproteinase-7 inc ...... nts with colorectal carcinoma.
@en
P2093
Huann-Sheng Wang
Po-Min Chen
Wei-Shu Wang
Wen-Yih Liang
P2860
P304
P356
10.1093/CARCIN/BGI351
P407
P577
2006-02-10T00:00:00Z